Results 171 to 180 of about 4,739 (204)
Some of the next articles are maybe not open access.
Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine
Vaccine, 1989Various approaches have been considered for generation of effective and safe vaccines against retroviruses, including HIV, with limited success. In the present vaccination study, encompassing 137 household cats, we have composed an experimental ISCOM subunit vaccine containing gp70 of feline leukaemia virus (FeLV)--the external glycosylated envelope ...
A, Osterhaus +6 more
openaire +4 more sources
Two cases of FeLV‐associated dermatoses
Veterinary Dermatology, 2005Abstract Two cases of feline leukaemia virus (FeLV)‐associated dermatosis are described. The first cat was affected by an ulcerative dermatitis identified as a giant‐cell dermatosis. The second case was a cutaneous lymphoma. In both cases, FeLV antigens and FeLV genome were demonstrated in the affected skin immunologically and with polymerase chain ...
Favrot, Claude +5 more
openaire +2 more sources
Vaccine, 2014
The aim of the study was to determine the efficacy of an inactivated feline leukemia virus (FeLV) vaccine (Versifel(®) FeLV, Zoetis.) compared to a recombinant FeLV vaccine (Purevax(®) FeLV, Merial Animal Health) in young cats, exposed under laboratory conditions to a highly virulent challenge model.
Kristin, Stuke +5 more
openaire +2 more sources
The aim of the study was to determine the efficacy of an inactivated feline leukemia virus (FeLV) vaccine (Versifel(®) FeLV, Zoetis.) compared to a recombinant FeLV vaccine (Purevax(®) FeLV, Merial Animal Health) in young cats, exposed under laboratory conditions to a highly virulent challenge model.
Kristin, Stuke +5 more
openaire +2 more sources
Biologicals, 2017
The purpose of this study was to compare the efficacy of three FeLV vaccines, under identical conditions in a laboratory challenge model that closely mimics natural infection. Four groups of cats (n = 20 per group) were administered two doses of vaccine, 21 days apart, starting at 9-10 weeks of age (Purevax® FeLV, Versifel® FeLV, Nobivac® feline 2-FeLV,
Deborah A, Grosenbaugh +5 more
openaire +2 more sources
The purpose of this study was to compare the efficacy of three FeLV vaccines, under identical conditions in a laboratory challenge model that closely mimics natural infection. Four groups of cats (n = 20 per group) were administered two doses of vaccine, 21 days apart, starting at 9-10 weeks of age (Purevax® FeLV, Versifel® FeLV, Nobivac® feline 2-FeLV,
Deborah A, Grosenbaugh +5 more
openaire +2 more sources
Virology, 1992
In efforts to elucidate the proximal leukemogens that might be produced during a feline leukemia virus (FeLV) infection of cats, homologous recombinations between molecularly cloned exogenous and endogenous FeLV proviruses of known sequences were examined in cell cultures in vitro.
R L, Sheets +4 more
openaire +2 more sources
In efforts to elucidate the proximal leukemogens that might be produced during a feline leukemia virus (FeLV) infection of cats, homologous recombinations between molecularly cloned exogenous and endogenous FeLV proviruses of known sequences were examined in cell cultures in vitro.
R L, Sheets +4 more
openaire +2 more sources
Panleukopenia-like syndrome of FeLV caused by co-infection with FeLV and feline panleukopenia virus
Veterinary Immunology and Immunopathology, 1995To study the effect of interferon on feline leukemia virus (FeLV) infection, 30 specific pathogen free (SPF) cats were infected with the apathogenic FeLV A Glasgow. Unexpectedly, between 5 and 8 weeks after FeLV infection, all 19 cats with persistent FeLV infection but not the FeLV-negative cats died from a panleukopenia-like syndrome.
H, Lutz +7 more
openaire +2 more sources
FeLV-FAIDS-induced immunodeficiency syndrome in cats
Veterinary Immunology and Immunopathology, 1989Findings are reviewed, relevant to elucidation of the pathogenic, genetic and biochemical properties of a single, genetically heterogeneous isolate of feline leukemia virus (FeLV-FAIDS) shown to induce fatal immunodeficiency disease in nearly 100% of inoculated cats.
J I, Mullins +5 more
openaire +2 more sources
Analytical Biochemistry, 1972
Abstract A procedure for determining the buoyant density of nucleic acids and/or other biological macromolecules using the preparative ultracentrifuge and a recording spectrophotometer via a specially adapted tube holder is described. The procedure gives buoyant density values, precise to ±0.004 gm cm −3 , which is comparable to determinations made ...
J L, Olpin, C L, Burger
openaire +2 more sources
Abstract A procedure for determining the buoyant density of nucleic acids and/or other biological macromolecules using the preparative ultracentrifuge and a recording spectrophotometer via a specially adapted tube holder is described. The procedure gives buoyant density values, precise to ±0.004 gm cm −3 , which is comparable to determinations made ...
J L, Olpin, C L, Burger
openaire +2 more sources
Treatment of feline leukemia virus (FeLV) infection
Veterinary Microbiology, 1999FeLV infection is still considered to account for most disease-related deaths in pet cats. Different treatment attempts with various drugs were performed in the past but none resulted in healing or complete virus elimination. Therefore, it caused a sensation when Horber and Mayr [Horber, D., Mayr, B., 1991. Prax.
K, Hartmann +5 more
openaire +2 more sources